Executive Summary
Today, more than two million children are marginalized by the devastating consequences of a severe yet preventable disability. Known as clubfoot, it affects 175,000 babies every year globally, but only 20 percent of children in low-income countries receive the treatment routinely provided elsewhere at birth. This solvable condition—a root cause of poverty—has fallen through the cracks of global development. A $500 solution changes the course of a child’s life forever, yet no one is funding it on a broad scale. $100 million will mobilize an unprecedented effort to end this historically neglected issue.
Over five years, MiracleFeet will build national treatment systems in 11 of the highest-need countries, addressing 50 percent of the world’s clubfoot cases. By creating local capacity to prevent this extreme disability in these countries and designing a roadmap for other countries to follow, millions of children will have the opportunity to achieve their dreams through lasting mobility.
Charity, fund, non-governmental organization, religious institution, school, or other entity
Organizations may provide budget and employee data based on this proposal or the organization as a whole. For more information on this proposal or organization, please email us.
Accomplishments
Despite the challenges of the COVID-19 pandemic, MiracleFeet continues to make major contributions to the growth, innovation, and quality of clubfoot treatment worldwide. In Fiscal Year 2022, made progress toward our goals for expansion and growth, increasing access to high-quality clubfoot treatment so that more children around the world can grow up without knowing the pain caused by untreated clubfoot. Monthly new-patient enrollments were consistently higher than pre-pandemic levels, and in total, we enrolled 11,129 children in treatment—more than any other year.
As of June 2022, MiracleFeet has reached 68,000 children, and supports over 330 clinics in 33 countries. Our focus on technology and data has been critical to our work to scale up access to high-quality clubfoot treatment in the highest-need countries this year. Real-time data from our program management tool, CAST, helped us navigate the shocks of COVID and tailor partner support and treatment protocols based on local realities. In addition, our digital training curricula for clubfoot treatment developed and piloted in the past year—ACT Online—already is filling a critical training gap amid social distancing requirements and travel restrictions.
